Skip to main content
. 2016 Feb 19;5(2):e002430. doi: 10.1161/JAHA.115.002430

Table 6.

Clinical Outcomes at 30 Days and 2 Years in Relation to Presence of CAD and Post‐TAVI Troponin >15× ULN vs ≤15× ULN

No CAD Adjusted HR (95% CI) Adjusted P Value CAD Adjusted HR (95% CI) Adjusted P Value
cTnT ≤15× ULN n=99 cTnT >15× ULN n=111 cTnT ≤15× ULN n=140 cTnT >15× ULN n=227
30 days
Death, n (%) 2 (2.0) 8 (7.2) 2.42 (0.50–11.59) 0.270 0 (0.0) 20 (8.8)
Cardiovascular death, n (%) 2 (2.0) 6 (5.5) 1.72 (0.34–8.76) 0.512 0 (0.0) 17 (7.5)
Cerebrovascular events 3 (3.0) 9 (8.1) 2.41 (0.64–9.10) 0.196 3 (2.1) 6 (2.7) 0.88 (0.21–3.70) 0.857
Death or major stroke, n (%) 3 (3.0) 12 (10.8) 2.79 (0.77–10.09) 0.118 1 (0.7) 23 (10.1) 12.70 (1.70–94.77) 0.013
Death, major stroke, or MI, n (%) 2 (2.0) 13 (11.7) 4.59 (1.01–20.73) 0.048 1 (0.7) 24 (10.6) 13.28 (1.78–98.87) 0.012
2 years
Death, n (%) 11 (11.6) 30 (29.5) 2.59 (1.27–5.26) 0.009 28 (20.8) 74 (33.1) 1.71 (1.10–2.65) 0.018
Cardiovascular death, n (%) 6 (6.4) 17 (17.5) 2.39 (0.91–6.26) 0.076 19 (14.4) 54 (25.0) 1.77 (1.04–3.01) 0.035
Cerebrovascular events 5 (5.3) 11 (10.8) 1.89 (0.64–5.57) 0.248 9 (7.0) 13 (6.8) 0.90 (0.38–2.14) 0.818
Death or major stroke, n (%) 14 (14.8) 35 (34.0) 2.38 (1.26–4.50) 0.008 30 (22.2) 77 (34.4) 1.67 (1.09–2.56) 0.019
Death, major stroke, or MI, n (%) 12 (12.7) 35 (33.9) 2.81 (1.44–5.51) 0.003 32 (23.7) 82 (36.6) 1.71 (1.13–2.58) 0.011

Depicted are number of first events (% cumulative incidence), hazard ratios (HRs) with respective 95% CIs from Cox's regressions. Adjusted HRs were obtained after adjusting for age, renal dysfunctions and STS score. Age, renal dysfunctions and STS score had a P<0.2 univariable effect on the primary outcome all‐cause death at 30 days. Missing data were singly imputed (n=1 for renal dysfunction and n=1 for STS score). CAD indicates coronary artery disease; cTnT, cardiac troponin T; MI, myocardial infarction; STS, Society of Thoracic Surgeons; TAVI; transcatheter aortic valve implantation; ULN, upper limit of normal.